Skip to content

Ardelyx ARDX Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Amgen logo
AmgenAMGN
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's unrealized gains on investments?
Ardelyx (ARDX) reported unrealized gains on investments of $22K in Q1 2026.
How has Ardelyx's unrealized gains on investments changed year-over-year?
Ardelyx's unrealized gains on investments decreased by 60.7% year-over-year, from $56K to $22K.
What is the long-term trend for Ardelyx's unrealized gains on investments?
Over 5 years (2020 to 2025), Ardelyx's unrealized gains on investments has grown at a 95.7% compound annual growth rate (CAGR), from $7K to $201K.
What does unrealized gains on investments mean?
This represents the cumulative increase in the fair market value of investment securities held by the company that have not yet been sold. It reflects the positive performance of the company's treasury or investment portfolio relative to the original cost basis. This metric provides insight into the unrealized wealth generated by the company's liquid asset management.